Company · PCVX
Vaxcyte, Inc.
Nasdaq's symbol directory lists PCVX on Nasdaq as “Vaxcyte, Inc. - Common Stock”.
In the 12 months to Nov 8, 2026: insiders sold on 17 occasions ($10.5M); 6 planned-sale notices; 4 filings by holders of 5% or more; 3 congressional trade disclosures; 3 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 11
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Grant Pickering, CHIEF EXECUTIVE OFFICER sold $3.6M
- Jim Wassil, EVP, Chief Scientific Ofc, COO sold $2.5M
- Elvia Cowan, SVP, Finance & CAO sold $1.8M
- Andrew Guggenhime, PRESIDENT AND CFO sold $1.6M
- Dhaliwal Harpreet S., Chief Technical Ops Officer sold $935K
Every trade (17)
- SELLElvia Cowan, SVP, Finance & CAO sold $183K
- SELLJim Wassil, EVP, Chief Scientific Ofc, COO sold $137K
- SELLElvia Cowan, SVP, Finance & CAO sold $1.6M
- SELLJim Wassil, EVP, Chief Scientific Ofc, COO sold $1.6M
- SELLJim Wassil, EVP, Chief Scientific Ofc, COO sold $128K
- SELLJim Wassil, EVP, Chief Scientific Ofc, COO sold $79K
- SELLJim Wassil, EVP, Chief Scientific Ofc, COO sold $84K
- SELLJim Wassil, CHIEF OPERATING OFFICER sold $212K
- SELLDhaliwal Harpreet S., Chief Technical Ops Officer sold $935K
- SELLAndrew Guggenhime, PRESIDENT AND CFO sold $539K
- SELLJim Wassil, CHIEF OPERATING OFFICER sold $121K
- SELLGrant Pickering, CHIEF EXECUTIVE OFFICER sold $1.0M
- SELLAndrew Guggenhime, PRESIDENT AND CFO sold $573K
- SELLJim Wassil, CHIEF OPERATING OFFICER sold $127K
- SELLGrant Pickering, CHIEF EXECUTIVE OFFICER sold $1.3M
- SELLGrant Pickering, CHIEF EXECUTIVE OFFICER sold $1.3M
- SELLAndrew Guggenhime, PRESIDENT AND CFO sold $530K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Cowan Elvia $186K
- Wassil Jim $139K
- Cowan Elvia $1.6M
- Wassil Jim $1.6M
- Wassil Jim $128K
- Wassil Jim $80K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- T. Rowe Price Investment Management, Inc. 11.6%
- Janus Henderson Group Ltd. 12.1%
- Janus Henderson Group Ltd. 0.1%
- FMR LLC 14.4%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
- Gilbert Cisneros (D-CA31): Purchase $1,001 - $15,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 4, 2026
- Entry into a material definitive agreement; Creation of a direct financial obligation; Other events Oct 9, 2026
- Regulation FD disclosure; Other events Oct 5, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.